par Gentet, J C;Brunat-Mentigny, M;Demaille, M C;Pein, F;Avet-Loiseau, Herve;Berger, C;De Lumley, L;Pacquement, H;Schmitt, Christian;Sariban, Eric 
;Pillon, P;Bernard, J L;Kalifa, C
Référence European journal of cancer, 33, 2, page (232-237)
Publication Publié, 1997-02
;Pillon, P;Bernard, J L;Kalifa, CRéférence European journal of cancer, 33, 2, page (232-237)
Publication Publié, 1997-02
Article révisé par les pairs
| Titre: |
|
| Auteur: | Gentet, J C; Brunat-Mentigny, M; Demaille, M C; Pein, F; Avet-Loiseau, Herve; Berger, C; De Lumley, L; Pacquement, H; Schmitt, Christian; Sariban, Eric; Pillon, P; Bernard, J L; Kalifa, C |
| Informations sur la publication: | European journal of cancer, 33, 2, page (232-237) |
| Statut de publication: | Publié, 1997-02 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adolescent |
| Adult | |
| Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Bone Neoplasms -- drug therapy | |
| Child | |
| Etoposide -- administration & dosage | |
| Etoposide -- adverse effects | |
| Female | |
| Humans | |
| Ifosfamide -- administration & dosage | |
| Ifosfamide -- adverse effects | |
| Male | |
| Osteosarcoma -- drug therapy | |
| Survival Rate | |
| Treatment Outcome | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase II | |
| Journal Article | |
| Research Support, Non-U.S. Gov't | |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0959-8049 |
| info:doi/10.1016/S0959-8049(96)00439-X | |
| info:pii/S095980499600439X | |
| info:scp/0030995153 | |
| info:pmid/9135494 |
